Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1994 Apr;160(4):343–350.

Melanoma risk factors and atypical moles.

M L Williams 1, R W Sagebiel 1
PMCID: PMC1022426  PMID: 8023484

Abstract

Despite important advances in the treatment of melanoma, the prognosis for advanced disease remains discouraging. This fact, in combination with a worldwide epidemic of melanoma among persons of white skin type, has focused attention on identifying melanoma in its early, surgically curable stages. Attention has also been directed toward pinpointing which persons are at increased risk for melanoma to reduce risk where possible and to aid early diagnosis. Essentially all epidemiologic studies have identified an increased number of melanocytic nevi as an important risk factor in the development of melanoma, but controversy has arisen concerning the risk associated with certain types of nevi, particularly "dysplastic" nevi. We review melanoma risk factors and examine the relationship between melanocytic nevi and melanoma to clarify for primary care physicians what is "known" (non-controversial) and what is "unknown" (controversial). We propose a working definition of an atypical mole phenotype and outline an approach to managing high-risk patients.

Full text

PDF
343

Images in this article

348Image
on p.348
348Image
on p.348

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman A. B. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology. 1988 Sep;13(3):241–256. doi: 10.1111/j.1365-2559.1988.tb02036.x. [DOI] [PubMed] [Google Scholar]
  2. Albert L. S., Rhodes A. R., Sober A. J. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. J Am Acad Dermatol. 1990 Jan;22(1):69–75. doi: 10.1016/0190-9622(90)70010-f. [DOI] [PubMed] [Google Scholar]
  3. Armstrong B. K. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol. 1988 Aug;14(8):835–849. doi: 10.1111/j.1524-4725.1988.tb03588.x. [DOI] [PubMed] [Google Scholar]
  4. Armstrong B. K., de Klerk N. H., Holman C. D. Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Natl Cancer Inst. 1986 Aug;77(2):329–335. [PubMed] [Google Scholar]
  5. Bale S. J., Dracopoli N. C., Tucker M. A., Clark W. H., Jr, Fraser M. C., Stanger B. Z., Green P., Donis-Keller H., Housman D. E., Greene M. H. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med. 1989 May 25;320(21):1367–1372. doi: 10.1056/NEJM198905253202102. [DOI] [PubMed] [Google Scholar]
  6. Beitner H., Norell S. E., Ringborg U., Wennersten G., Mattson B. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol. 1990 Jan;122(1):43–51. doi: 10.1111/j.1365-2133.1990.tb08238.x. [DOI] [PubMed] [Google Scholar]
  7. Bergman W., Palan A., Went L. N. Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome. Ann Hum Genet. 1986 Jul;50(Pt 3):249–258. doi: 10.1111/j.1469-1809.1986.tb01046.x. [DOI] [PubMed] [Google Scholar]
  8. Cannon-Albright L. A., Goldgar D. E., Meyer L. J., Lewis C. M., Anderson D. E., Fountain J. W., Hegi M. E., Wiseman R. W., Petty E. M., Bale A. E. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science. 1992 Nov 13;258(5085):1148–1152. doi: 10.1126/science.1439824. [DOI] [PubMed] [Google Scholar]
  9. Cannon-Albright L. A., Goldgar D. E., Wright E. C., Turco A., Jost M., Meyer L. J., Piepkorn M., Zone J. J., Skolnick M. H. Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36. Am J Hum Genet. 1990 May;46(5):912–918. [PMC free article] [PubMed] [Google Scholar]
  10. Castilla E. E., da Graça Dutra M., Orioli-Parreiras I. M. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol. 1981 Mar;104(3):307–315. doi: 10.1111/j.1365-2133.1981.tb00954.x. [DOI] [PubMed] [Google Scholar]
  11. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Epstein M. N., Greene M. H., Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984 Dec;15(12):1147–1165. doi: 10.1016/s0046-8177(84)80310-x. [DOI] [PubMed] [Google Scholar]
  12. Clark W. H., Jr, Reimer R. R., Greene M., Ainsworth A. M., Mastrangelo M. J. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol. 1978 May;114(5):732–738. [PubMed] [Google Scholar]
  13. Clemmensen O. J., Kroon S. The histology of "congenital features" in early acquired melanocytic nevi. J Am Acad Dermatol. 1988 Oct;19(4):742–746. doi: 10.1016/s0190-9622(88)70231-5. [DOI] [PubMed] [Google Scholar]
  14. Crutcher W. A., Sagebiel R. W. Prevalence of dysplastic naevi in a community practice. Lancet. 1984 Mar 31;1(8379):729–729. doi: 10.1016/s0140-6736(84)92235-9. [DOI] [PubMed] [Google Scholar]
  15. DeCoste S. D., Stern R. S. Diagnosis and treatment of nevomelanocytic lesions of the skin. A community-based study. Arch Dermatol. 1993 Jan;129(1):57–62. [PubMed] [Google Scholar]
  16. Duvic M., Lowe L., Rapini R. P., Rodriguez S., Levy M. L. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol. 1989 Mar;125(3):397–401. [PubMed] [Google Scholar]
  17. Easton D. F., Cox G. M., Macdonald A. M., Ponder B. A. Genetic susceptibility to naevi--a twin study. Br J Cancer. 1991 Dec;64(6):1164–1167. doi: 10.1038/bjc.1991.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Elder D. E., Goldman L. I., Goldman S. C., Greene M. H., Clark W. H., Jr Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980 Oct 15;46(8):1787–1794. doi: 10.1002/1097-0142(19801015)46:8<1787::aid-cncr2820460816>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  19. Elder D. E., Green M. H., Guerry D., 4th, Kraemer K. H., Clark W. H., Jr The dysplastic nevus syndrome: our definition. Am J Dermatopathol. 1982 Oct;4(5):455–460. doi: 10.1097/00000372-198210000-00014. [DOI] [PubMed] [Google Scholar]
  20. Elder D. E. The dysplastic nevus. Pathology. 1985 Apr;17(2):291–297. doi: 10.3109/00313028509063770. [DOI] [PubMed] [Google Scholar]
  21. Elwood J. M., Gallagher R. P., Davison J., Hill G. B. Sunburn, suntan and the risk of cutaneous malignant melanoma--The Western Canada Melanoma Study. Br J Cancer. 1985 Apr;51(4):543–549. doi: 10.1038/bjc.1985.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Elwood J. M., Gallagher R. P., Hill G. B., Pearson J. C. Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study. Int J Cancer. 1985 Apr 15;35(4):427–433. doi: 10.1002/ijc.2910350403. [DOI] [PubMed] [Google Scholar]
  23. Elwood J. M., Gallagher R. P., Hill G. B., Spinelli J. J., Pearson J. C., Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J (Clin Res Ed) 1984 Jan 14;288(6411):99–102. doi: 10.1136/bmj.288.6411.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Evans R. D., Kopf A. W., Lew R. A., Rigel D. S., Bart R. S., Friedman R. J., Rivers J. K. Risk factors for the development of malignant melanoma--I: Review of case-control studies. J Dermatol Surg Oncol. 1988 Apr;14(4):393–408. doi: 10.1111/j.1524-4725.1988.tb03373.x. [DOI] [PubMed] [Google Scholar]
  25. Frichot B. C., 3rd, Lynch H. T., Guirgis H. A., Harris R. E., Lynch J. F. New cutaneous phenotype in familial malignant melanoma. Lancet. 1977 Apr 16;1(8016):864–865. doi: 10.1016/s0140-6736(77)92822-7. [DOI] [PubMed] [Google Scholar]
  26. Friedman R. J., Rigel D. S., Silverman M. K., Kopf A. W., Vossaert K. A. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1991 Jul-Aug;41(4):201–226. doi: 10.3322/canjclin.41.4.201. [DOI] [PubMed] [Google Scholar]
  27. Gallagher R. P., McLean D. I., Yang C. P., Coldman A. J., Silver H. K., Spinelli J. J., Beagrie M. Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study. Arch Dermatol. 1990 Apr;126(4):466–471. [PubMed] [Google Scholar]
  28. Gallagher R. P., McLean D. I., Yang C. P., Coldman A. J., Silver H. K., Spinelli J. J., Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol. 1990 Jun;126(6):770–776. [PubMed] [Google Scholar]
  29. Garbe C., Krüger S., Stadler R., Guggenmoos-Holzmann I., Orfanos C. E. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol. 1989 Oct;28(8):517–523. doi: 10.1111/j.1365-4362.1989.tb04604.x. [DOI] [PubMed] [Google Scholar]
  30. Goldgar D. E., Cannon-Albright L. A., Meyer L. J., Piepkorn M. W., Zone J. J., Skolnick M. H. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst. 1991 Dec 4;83(23):1726–1733. doi: 10.1093/jnci/83.23.1726. [DOI] [PubMed] [Google Scholar]
  31. Graham S., Marshall J., Haughey B., Stoll H., Zielezny M., Brasure J., West D. An inquiry into the epidemiology of melanoma. Am J Epidemiol. 1985 Oct;122(4):606–619. doi: 10.1093/oxfordjournals.aje.a114140. [DOI] [PubMed] [Google Scholar]
  32. Green A., MacLennan R., Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985 Mar 15;35(3):297–300. doi: 10.1002/ijc.2910350303. [DOI] [PubMed] [Google Scholar]
  33. Green A., Sorahan T., Pope D., Siskind V., Hansen M., Hanson L., Leech P., Ball P. M., Grimley R. P. Moles in Australian and British school children. Lancet. 1988 Dec 24;2(8626-8627):1497–1497. doi: 10.1016/s0140-6736(88)90980-4. [DOI] [PubMed] [Google Scholar]
  34. Greene M. H., Clark W. H., Jr, Tucker M. A., Elder D. E., Kraemer K. H., Guerry D., 4th, Witmer W. K., Thompson J., Matozzo I., Fraser M. C. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med. 1985 Jan 10;312(2):91–97. doi: 10.1056/NEJM198501103120205. [DOI] [PubMed] [Google Scholar]
  35. Greene M. H., Clark W. H., Jr, Tucker M. A., Kraemer K. H., Elder D. E., Fraser M. C. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985 Apr;102(4):458–465. doi: 10.7326/0003-4819-102-4-458. [DOI] [PubMed] [Google Scholar]
  36. Gruis N. A., Bergman W., Frants R. R. Locus for susceptibility to melanoma on chromosome lp. N Engl J Med. 1990 Mar 22;322(12):853–854. doi: 10.1056/nejm199003223221217. [DOI] [PubMed] [Google Scholar]
  37. Halpern A. C., Guerry D., 4th, Elder D. E., Clark W. H., Jr, Synnestvedt M., Norman S., Ayerle R. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol. 1991 Jul;127(7):995–999. [PubMed] [Google Scholar]
  38. Holly E. A., Kelly J. W., Shpall S. N., Chiu S. H. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987 Sep;17(3):459–468. doi: 10.1016/s0190-9622(87)70230-8. [DOI] [PubMed] [Google Scholar]
  39. Houghton A. N., Viola M. V. Solar radiation and malignant melanoma of the skin. J Am Acad Dermatol. 1981 Oct;5(4):477–483. doi: 10.1016/s0190-9622(81)70109-9. [DOI] [PubMed] [Google Scholar]
  40. Hughes B. R., Cunliffe W. J., Bailey C. C. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ. 1989 Jul 8;299(6691):88–91. doi: 10.1136/bmj.299.6691.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kadonaga J. N., Frieden I. J. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991 May;24(5 Pt 1):747–755. doi: 10.1016/0190-9622(91)70115-i. [DOI] [PubMed] [Google Scholar]
  42. Kaplan E. N. The risk of malignancy in large congenital nevi. Plast Reconstr Surg. 1974 Apr;53(4):421–428. doi: 10.1097/00006534-197404000-00007. [DOI] [PubMed] [Google Scholar]
  43. Kefford R. F., Salmon J., Shaw H. M., Donald J. A., McCarthy W. H. Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p. Cancer Genet Cytogenet. 1991 Jan;51(1):45–55. doi: 10.1016/0165-4608(91)90007-h. [DOI] [PubMed] [Google Scholar]
  44. Kelly J. W., Crutcher W. A., Sagebiel R. W. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation. J Am Acad Dermatol. 1986 Jun;14(6):1044–1052. doi: 10.1016/s0190-9622(86)70131-x. [DOI] [PubMed] [Google Scholar]
  45. Kenet R. O., Kang S., Kenet B. J., Fitzpatrick T. B., Sober A. J., Barnhill R. L. Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol. 1993 Feb;129(2):157–174. [PubMed] [Google Scholar]
  46. Koh H. K. Cutaneous melanoma. N Engl J Med. 1991 Jul 18;325(3):171–182. doi: 10.1056/NEJM199107183250306. [DOI] [PubMed] [Google Scholar]
  47. Kopf A. W., Bart R. S., Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol. 1979 Aug;1(2):123–130. doi: 10.1016/s0190-9622(79)70009-0. [DOI] [PubMed] [Google Scholar]
  48. Kopf A. W., Friedman R. J., Rigel D. S. Atypical mole syndrome. J Am Acad Dermatol. 1990 Jan;22(1):117–118. doi: 10.1016/s0190-9622(08)80006-0. [DOI] [PubMed] [Google Scholar]
  49. Kopf A. W., Lazar M., Bart R. S., Dubin N., Bromberg J. Prevalence of nevocytic nevi on lateral and medial aspects of arms. J Dermatol Surg Oncol. 1978 Feb;4(2):153–158. doi: 10.1111/j.1524-4725.1978.tb00398.x. [DOI] [PubMed] [Google Scholar]
  50. Kopf A. W., Lindsay A. C., Rogers G. S., Friedman R. J., Rigel D. S., Levenstein M. Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome. J Am Acad Dermatol. 1985 Apr;12(4):656–662. doi: 10.1016/s0190-9622(85)70090-4. [DOI] [PubMed] [Google Scholar]
  51. Kraemer K. H., Greene M. H., Tarone R., Elder D. E., Clark W. H., Jr, Guerry D., 4th Dysplastic naevi and cutaneous melanoma risk. Lancet. 1983 Nov 5;2(8358):1076–1077. doi: 10.1016/s0140-6736(83)91055-3. [DOI] [PubMed] [Google Scholar]
  52. Kraemer K. H., Lee M. M., Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987 Feb;123(2):241–250. doi: 10.1001/archderm.123.2.241. [DOI] [PubMed] [Google Scholar]
  53. Krüger S., Garbe C., Büttner P., Stadler R., Guggenmoos-Holzmann I., Orfanos C. E. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol. 1992 Jun;26(6):920–926. doi: 10.1016/0190-9622(92)70133-z. [DOI] [PubMed] [Google Scholar]
  54. LEMLI L., SMITH D. W. THE XO SYNDROME. A STUDY OF THE DIFFERENTIATED PHENOTYPE IN 25 PATIENTS. J Pediatr. 1963 Oct;63:577–588. doi: 10.1016/s0022-3476(63)80368-6. [DOI] [PubMed] [Google Scholar]
  55. Lee P. Y., Silverman M. K., Rigel D. S., Vossaert K. A., Kopf A. W., Bart R. S., Garfinkel L., Levenstein M. J. Level of education and the risk of malignant melanoma. J Am Acad Dermatol. 1992 Jan;26(1):59–63. doi: 10.1016/0190-9622(92)70007-3. [DOI] [PubMed] [Google Scholar]
  56. Lew R. A., Sober A. J., Cook N., Marvell R., Fitzpatrick T. B. Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol. 1983 Dec;9(12):981–986. doi: 10.1111/j.1524-4725.1983.tb01051.x. [DOI] [PubMed] [Google Scholar]
  57. Lynch H. T., Frichot B. C., 3rd, Lynch J. F. Familial atypical multiple mole-melanoma syndrome. J Med Genet. 1978 Oct;15(5):352–356. doi: 10.1136/jmg.15.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Lynch H. T., Fusaro R. M., Albano W. A., Pester J., Kimberling W. J., Lynch J. F. Phenotypic variation in the familial atypical multiple mole-melanoma syndrome (FAMMM). J Med Genet. 1983 Feb;20(1):25–29. doi: 10.1136/jmg.20.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. MacKie R. M., Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. Br J Cancer. 1982 Dec;46(6):955–960. doi: 10.1038/bjc.1982.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. MacKie R. M., English J., Aitchison T. C., Fitzsimons C. P., Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985 Aug;113(2):167–174. doi: 10.1111/j.1365-2133.1985.tb02060.x. [DOI] [PubMed] [Google Scholar]
  61. MacKie R. M., Freudenberger T., Aitchison T. C. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989 Aug 26;2(8661):487–490. doi: 10.1016/s0140-6736(89)92097-7. [DOI] [PubMed] [Google Scholar]
  62. Masri G. D., Clark W. H., Jr, Guerry D., 4th, Halpern A., Thompson C. J., Elder D. E. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1042–1048. doi: 10.1016/0190-9622(90)70149-c. [DOI] [PubMed] [Google Scholar]
  63. McHenry P. M., Hole D. J., MacKie R. M. Melanoma in people aged 65 and over in Scotland, 1979-89. BMJ. 1992 Mar 21;304(6829):746–749. doi: 10.1136/bmj.304.6829.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Nancarrow D. J., Palmer J. M., Walters M. K., Kerr B. M., Hafner G. J., Garske L., McLeod G. R., Hayward N. K. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees. Genomics. 1992 Jan;12(1):18–25. doi: 10.1016/0888-7543(92)90401-d. [DOI] [PubMed] [Google Scholar]
  65. Nicholls E. M. Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer. 1973 Jul;32(1):191–195. doi: 10.1002/1097-0142(197307)32:1<191::aid-cncr2820320129>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  66. Nordlund J. J., Kirkwood J., Forget B. M., Scheibner A., Albert D. M., Lerner E., Milton G. W. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985 Apr;45(4):1855–1861. [PubMed] [Google Scholar]
  67. Perednia D. A. What dermatologists should know about digital imaging. J Am Acad Dermatol. 1991 Jul;25(1 Pt 1):89–108. doi: 10.1016/0190-9622(91)70178-5. [DOI] [PubMed] [Google Scholar]
  68. Piepkorn M., Meyer L. J., Goldgar D., Seuchter S. A., Cannon-Albright L. A., Skolnick M. H., Zone J. J. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol. 1989 Mar;20(3):407–415. doi: 10.1016/s0190-9622(89)70050-5. [DOI] [PubMed] [Google Scholar]
  69. Pope D. J., Sorahan T., Marsden J. R., Ball P. M., Grimley R. P., Peck I. M. Benign pigmented nevi in children. Prevalence and associated factors: the West Midlands, United Kingdom Mole Study. Arch Dermatol. 1992 Sep;128(9):1201–1206. doi: 10.1001/archderm.128.9.1201. [DOI] [PubMed] [Google Scholar]
  70. Quaba A. A., Wallace A. F. The incidence of malignant melanoma (0 to 15 years of age) arising in "large" congenital nevocellular nevi. Plast Reconstr Surg. 1986 Aug;78(2):174–181. doi: 10.1097/00006534-198608000-00004. [DOI] [PubMed] [Google Scholar]
  71. Rampen F. H., van der Meeren H. L., Boezeman J. B. Frequency of moles as a key to melanoma incidence? J Am Acad Dermatol. 1986 Dec;15(6):1200–1203. doi: 10.1016/s0190-9622(86)70290-9. [DOI] [PubMed] [Google Scholar]
  72. Rapini R. P. Photographs for Clark's "dysplastic" nevi? J Am Acad Dermatol. 1988 Dec;19(6):1130–1134. doi: 10.1016/s0190-9622(98)80017-0. [DOI] [PubMed] [Google Scholar]
  73. Reintgen D. S., McCarty K. M., Jr, Cox E., Seigler H. F. Malignant melanoma in black American and white American populations. A comparative review. JAMA. 1982 Oct 15;248(15):1856–1859. [PubMed] [Google Scholar]
  74. Rhodes A. R., Silverman R. A., Harrist T. J., Melski J. W. A histologic comparison of congenital and acquired nevomelanocytic nevi. Arch Dermatol. 1985 Oct;121(10):1266–1273. [PubMed] [Google Scholar]
  75. Rhodes A. R., Weinstock M. A., Fitzpatrick T. B., Mihm M. C., Jr, Sober A. J. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA. 1987 Dec 4;258(21):3146–3154. [PubMed] [Google Scholar]
  76. Rhodes A. R., Wood W. C., Sober A. J., Mihm M. C., Jr Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg. 1981 Jun;67(6):782–790. doi: 10.1097/00006534-198106000-00012. [DOI] [PubMed] [Google Scholar]
  77. Rigel D. S., Rivers J. K., Kopf A. W., Friedman R. J., Vinokur A. F., Heilman E. R., Levenstein M. Dysplastic nevi. Markers for increased risk for melanoma. Cancer. 1989 Jan 15;63(2):386–389. doi: 10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  78. Ross P. M. Apparent absence of a benign precursor lesion: implications for the pathogenesis of malignant melanoma. J Am Acad Dermatol. 1989 Sep;21(3 Pt 1):529–538. doi: 10.1016/s0190-9622(89)70221-8. [DOI] [PubMed] [Google Scholar]
  79. Roth M. E., Grant-Kels J. M., Kuhn M. K., Greenberg R. D., Hurwitz S. Melanoma in children. J Am Acad Dermatol. 1990 Feb;22(2 Pt 1):265–274. doi: 10.1016/0190-9622(90)70036-h. [DOI] [PubMed] [Google Scholar]
  80. Roush G. C., Barnhill R. L., Duray P. H., Titus L. J., Ernstoff M. S., Kirkwood J. M. Diagnosis of the dysplastic nevus in different populations. J Am Acad Dermatol. 1986 Mar;14(3):419–425. doi: 10.1016/s0190-9622(86)70051-0. [DOI] [PubMed] [Google Scholar]
  81. Ruiz-Maldonado R., Tamayo L., Laterza A. M., Durán C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992 Jun;120(6):906–911. doi: 10.1016/s0022-3476(05)81958-4. [DOI] [PubMed] [Google Scholar]
  82. Schneider J. S., Moore D. H., 2nd, Sagebiel R. W. Melanoma predicted by clinically atypical moles. Lancet. 1992 Jun 13;339(8807):1492–1492. doi: 10.1016/0140-6736(92)92099-2. [DOI] [PubMed] [Google Scholar]
  83. Shriner D. L., Wagner R. F., Jr Photographic utilization in dermatology clinics in the United States: a survey of university-based dermatology residency programs. J Am Acad Dermatol. 1992 Oct;27(4):565–567. doi: 10.1016/0190-9622(92)70223-3. [DOI] [PubMed] [Google Scholar]
  84. Smith C. H., McGregor J. M., Barker J. N., Morris R. W., Rigden S. P., MacDonald D. M. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol. 1993 Jan;28(1):51–55. doi: 10.1016/0190-9622(93)70008-h. [DOI] [PubMed] [Google Scholar]
  85. Sorahan T., Ball P. M., Grimley R. P., Pope D. Benign pigmented nevi in children from Kidderminster, England: prevalence and associated factors. J Am Acad Dermatol. 1990 May;22(5 Pt 1):747–750. doi: 10.1016/0190-9622(90)70102-n. [DOI] [PubMed] [Google Scholar]
  86. Stolz W., Schmoeckel C., Landthaler M., Braun-Falco O. Association of early malignant melanoma with nevocytic nevi. Cancer. 1989 Feb 1;63(3):550–555. doi: 10.1002/1097-0142(19890201)63:3<550::aid-cncr2820630325>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  87. Swerdlow A. J., English J., MacKie R. M., O'Doherty C. J., Hunter J. A., Clark J. Benign naevi associated with high risk of melanoma. Lancet. 1984 Jul 21;2(8395):168–168. doi: 10.1016/s0140-6736(84)91086-9. [DOI] [PubMed] [Google Scholar]
  88. Swerdlow A. J., Green A. Melanocytic naevi and melanoma: an epidemiological perspective. Br J Dermatol. 1987 Aug;117(2):137–146. doi: 10.1111/j.1365-2133.1987.tb04109.x. [DOI] [PubMed] [Google Scholar]
  89. Tiersten A. D., Grin C. M., Kopf A. W., Gottlieb G. J., Bart R. S., Rigel D. S., Friedman R. J., Levenstein M. J. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. J Dermatol Surg Oncol. 1991 Jan;17(1):44–48. doi: 10.1111/j.1524-4725.1991.tb01592.x. [DOI] [PubMed] [Google Scholar]
  90. Tucker M. A., Crutcher W. A., Hartge P., Sagebiel R. W. Familial and cutaneous features of dysplastic nevi: a case-control study. J Am Acad Dermatol. 1993 Apr;28(4):558–564. doi: 10.1016/0190-9622(93)70074-4. [DOI] [PubMed] [Google Scholar]
  91. Tucker M. A., Greene M. H., Clark W. H., Jr, Kraemer K. H., Fraser M. C., Elder D. E. Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr. 1983 Jul;103(1):65–69. doi: 10.1016/s0022-3476(83)80777-x. [DOI] [PubMed] [Google Scholar]
  92. Tucker S. B., Horstmann J. P., Hertel B., Aranha G., Rosai J. Activation of nevi in patients with malignant melanoma. Cancer. 1980 Aug 15;46(4):822–827. doi: 10.1002/1097-0142(19800815)46:4<822::aid-cncr2820460430>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  93. Vink J., Crijns M. B., Mooy C. M., Bergman W., Oosterhuis J. A., Went L. N. Ocular melanoma in families with dysplastic nevus syndrome. J Am Acad Dermatol. 1990 Nov;23(5 Pt 1):858–862. doi: 10.1016/0190-9622(90)70304-z. [DOI] [PubMed] [Google Scholar]
  94. Vollenweider Roten S., Masouyé I., Delozier-Blanchet C. D., Saurat J. H. Cutaneous findings in ring chromosome 7 syndrome. Dermatology. 1993;186(2):84–87. doi: 10.1159/000247313. [DOI] [PubMed] [Google Scholar]
  95. Weinstock M. A., Colditz G. A., Willett W. C., Stampfer M. J., Bronstein B. R., Mihm M. C., Jr, Speizer F. E. Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics. 1989 Aug;84(2):199–204. [PubMed] [Google Scholar]
  96. Weiss J., Bertz J., Jung E. G. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica. 1991;183(2):109–113. doi: 10.1159/000247648. [DOI] [PubMed] [Google Scholar]
  97. de Wit P. E., de Vaan G. A., de Boo T. M., Lemmens W. A., Rampen F. H. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med Pediatr Oncol. 1990;18(4):336–338. doi: 10.1002/mpo.2950180417. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES